XML 8 R2.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2024
Dec. 31, 2023
Current assets    
Cash and cash equivalents $ 26,528,792 $ 40,912,575
Restricted cash 100,000 100,000
Prepaid expenses and other current assets 1,307,345 989,865
Total current assets 27,936,137 42,002,440
Equipment, net 6,802 10,884
Capitalized software, net 0 17,027
Goodwill 14,869,399 14,869,399
Total assets 42,812,338 56,899,750
Current liabilities    
Accounts payable 553,192 1,805,320
Accrued expenses and other current liabilities 3,929,848 1,535,097
Total current liabilities 4,483,040 3,340,417
Liability related to the sale of future royalties 60,000,000 82,016,823
Total liabilities 64,483,040 85,357,240
Commitments and contingencies (Note 8)
Stockholders' deficit    
Preferred stock; $0.0001 par value; 100,000,000 shares authorized; none issued or outstanding as of September 30, 2024 and December 31, 2023
Common stock; $0.0001 par value; 125,000,000 shares authorized; 6,993,406 shares issued and outstanding as of September 30, 2024 and December 31, 2023 699 699
Additional paid-in capital 369,433,114 368,357,239
Accumulated deficit (391,104,515) (396,815,428)
Total stockholders' deficit (21,670,702) (28,457,490)
Total liabilities and stockholders' deficit $ 42,812,338 $ 56,899,750